RadNet Cost of Goods Sold 2010-2024 | RDNT

RadNet cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
RadNet Annual Cost of Goods Sold
(Millions of US $)
2023 $1,395
2022 $1,264
2021 $1,123
2020 $966
2019 $1,000
2018 $868
2017 $802
2016 $776
2015 $708
2014 $603
2013 $599
2012 $543
2011 $478
2010 $421
2009 $398
RadNet Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $392
2024-06-30 $390
2024-03-31 $388
2023-12-31 $357
2023-09-30 $342
2023-06-30 $345
2023-03-31 $352
2022-12-31 $330
2022-09-30 $314
2022-06-30 $306
2022-03-31 $315
2021-12-31 $285
2021-09-30 $273
2021-06-30 $284
2021-03-31 $282
2020-12-31 $258
2020-09-30 $246
2020-06-30 $194
2020-03-31 $267
2019-12-31 $256
2019-09-30 $254
2019-06-30 $247
2019-03-31 $243
2018-12-31 $233
2018-09-30 $209
2018-06-30 $210
2018-03-31 $216
2017-12-31 $200
2017-09-30 $198
2017-06-30 $199
2017-03-31 $205
2016-12-31 $192
2016-09-30 $193
2016-06-30 $194
2016-03-31 $197
2015-12-31 $188
2015-09-30 $176
2015-06-30 $176
2015-03-31 $169
2014-12-31 $157
2014-09-30 $153
2014-06-30 $148
2014-03-31 $145
2013-12-31 $149
2013-09-30 $152
2013-06-30 $149
2013-03-31 $150
2012-12-31 $138
2012-09-30 $133
2012-06-30 $137
2012-03-31 $135
2011-12-31 $125
2011-09-30 $118
2011-06-30 $119
2011-03-31 $116
2010-12-31 $109
2010-09-30 $107
2010-06-30 $106
2010-03-31 $99
2009-12-31 $99
2009-09-30 $102
2009-06-30 $100
2009-03-31 $97
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.972B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.703B 0.00
Quest Diagnostics (DGX) United States $17.349B 17.58
DaVita (DVA) United States $14.249B 18.43
Encompass Health (EHC) United States $9.629B 22.70
Chemed (CHE) United States $8.394B 25.80
Elanco Animal Health (ELAN) United States $6.076B 14.46
Option Care Health (OPCH) United States $5.267B 24.96
LifeStance Health (LFST) United States $3.092B 0.00
Amedisys (AMED) United States $3.023B 21.51
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $2.076B 28.39
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.945B 38.21
Aveanna Healthcare Holdings (AVAH) United States $0.945B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00